Cargando…
Successful response with romidepsin in relapsed peripheral T-cell lymphoma, not otherwise specified with leukemic progression
Autores principales: | Sato, Shuku, Tamai, Yotaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536561/ https://www.ncbi.nlm.nih.gov/pubmed/32747612 http://dx.doi.org/10.5045/br.2020.2020045 |
Ejemplares similares
-
Peripheral T Cell Lymphoma: Not Otherwise Specified
por: Pai, Anusha H, et al.
Publicado: (2015) -
Peripheral T-cell lymphoma, not otherwise specified
por: Jha, Kunal Kishor, et al.
Publicado: (2017) -
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma
por: Pro, Barbara, et al.
Publicado: (2016) -
Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis
por: Schatz, J H, et al.
Publicado: (2015) -
Peripheral T-cell lymphoma, not otherwise specified- Case report
por: Khan, Nariman, et al.
Publicado: (2020)